23andme anne wojcicki

News

Ann Wojcicki's TTAM to Acquire 23andMe for $305M

Digest more

MedTech Dive · 18m

Anne Wojcicki wins bid to buy back 23andMe for $305M

A nonprofit led by the co-founder and former CEO of 23andMe outbid competitors for nearly all of the company’s assets.

· 7h · on MSN

Anne Wojcicki's bid to buy back 23andMe may not end a legal fight over DNA customer data

· 1d · on MSN

Nonprofit run by former CEO Anne Wojcicki wins bid to acquire 23andMe

2hon MSN

Regeneron is said to have declined a higher bid for 23andMe after Wojcicki's offer

Regeneron Pharmaceuticals (NASDAQ:REGN) has reportedly declined to submit a higher bid for 23andMe (OTC:MEHCQ) after a ...

1hon MSN

Anne Wojcicki's bid to buy back 23andMe may not end legal fight over DNA customer data

Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

Ann Wojcicki's TTAM to Acquire 23andMe for $305M

Trending now